Suppr超能文献

欧盟中药生产所用草药原料及草药制剂质量的法律要求。

Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.

作者信息

Vlietinck Arnold, Pieters Luc, Apers Sandra

机构信息

Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.

出版信息

Planta Med. 2009 Jun;75(7):683-8. doi: 10.1055/s-0029-1185307. Epub 2009 Feb 9.

Abstract

In the European Union (EU) herbal medicinal products have become increasingly important. This is, for instance, underlined by the recent introduction of a simplified procedure in the Member States of the EU allowing the registration of herbal medicinal products which fulfill the criteria of a traditional herbal medicinal product, i.e., sufficient evidence of its medicinal use throughout a period of at least 30 years for products in the EU and at least 15 years within the EU and 15 years elsewhere for products outside the EU. With regard to the manufacturing of these products and their quality, applications of traditional herbal medicinal products have to fulfil the same requirements as applications for a marketing authorization. The quality of herbal substances as well as herbal preparations will be determined by the availability of modern science-based public monographs in the European Pharmacopoeia and their equivalents developed by the pharmaceutical industry. The standards put forward in these monographs must allow us not only to define the quality of these products, but also to eliminate dangerous counterfeit, substandard, adulterated and contaminated (traditional) herbal medicinal products. The usefulness of these monographs to implement the criteria on quality and specifications put forward for these products in the different guidelines of the European Medicines Agency (EMEA) is discussed.

摘要

在欧盟,草药产品变得越来越重要。例如,欧盟成员国最近采用的简化程序就凸显了这一点,该程序允许对符合传统草药产品标准的草药产品进行注册,即对于欧盟境内的产品,有至少30年的药用历史证据;对于欧盟境外的产品,在欧盟境内有至少15年的药用历史证据,在其他地区有至少15年的药用历史证据。关于这些产品的生产及其质量,传统草药产品的申请必须满足与上市许可申请相同的要求。草药原料以及草药制剂的质量将由《欧洲药典》中基于现代科学的通用标准以及制药行业制定的等效标准来决定。这些通用标准中提出的标准必须使我们不仅能够界定这些产品的质量,而且能够消除危险的假冒、不合格、掺假和受污染的(传统)草药产品。本文讨论了这些通用标准对于实施欧洲药品管理局(EMEA)不同指南中针对这些产品提出的质量和规格标准的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验